Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michele Kirschenbaum"'
Autor:
Christina H. Wei, Denis O'Meally, Michele Kirschenbaum, Allen Mao, Chetan Kancharla, Kevin V. Morris, Daphne Stewart
Publikováno v:
Cancer Research. 82:P3-10
BACKGROUND: RNA-based predictive biomarkers are not assessed in the clinical diagnostic setting. Potential biomarkers include long noncoding RNAs (lncRNAs), a class of molecules emerging as critical regulators of diverse cellular functions, including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83df801729eb3583d73a4fb5fc0bad33
https://doi.org/10.1158/1538-7445.sabcs21-p3-10-05
https://doi.org/10.1158/1538-7445.sabcs21-p3-10-05
Autor:
Christina Wei, Michele Kirschenbaum, Chetan Kancharla, Laura Kruper, Ernest Han, Edward Wang, Mihaela Cristea, Daphne Stewart
Publikováno v:
Cancer Genetics. :9-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a6c4447400f7d510e8f6685042fdce
https://doi.org/10.1016/j.cancergen.2021.05.041
https://doi.org/10.1016/j.cancergen.2021.05.041
Autor:
Nayana Vora, Michele Kirschenbaum, George Somlo, Paul Frankel, Thehang Luu, Sally Shaw, John H. Yim, Laura Kruper, Jing Zhai, Arvind Manohar Shinde, Courtney Vito, Kim Wai Yu
Publikováno v:
The Breast. 24:18-23
Background Pathologic complete response (pCR) to neoadjuvant chemotherapy (NCT) is considered a surrogate for improved survival. Platinum-containing NCT, particularly in patients with HER2+ and triple-negative breast cancers (TNBC) may increase pCR r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71267fd17960add5e5a9988026f8a3f
https://doi.org/10.1016/j.breast.2014.10.008
https://doi.org/10.1016/j.breast.2014.10.008
Autor:
Joanne E. Mortimer, Arti Hurria, Masaya Kai, Meng Yin Hsieh, Duc Nguyen, Shiuan Chen, Paul Frankel, Chu Peiguo, Shang Wu, Laura Kruper, John H. Yim, Noriko Kanaya, Courtney Vito, Yuan Yuan, Nymph Chan, Jun Wu, George Somlo, Behnam Badie, Xueli Liu, Michele Kirschenbaum
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 170
The research was to appraise the utility of the patient-derived tumor xenografts (PDXs) as models of estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers. We compared protein expression profiles by Reverse Phase Protein Array (RPPA) in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baea9a5dbbab22f2f0704d91d0a45898
https://pubmed.ncbi.nlm.nih.gov/27154416
https://pubmed.ncbi.nlm.nih.gov/27154416
Autor:
Jun Wu, Y Yuan, Michele Kirschenbaum, Nymph Chan, George Somlo, Paul Frankel, Masaya Kai, Duc Nguyen, Shiuan Chen, Noriko Kanaya, Shang Wu, Joanne E. Mortimer, H Meng-Yin, Arti Hurria, Courtney Vito, Laura Kruper
Publikováno v:
Cancer Research. 76:P3-03
Background and Purpose: Despite recent progress in our endocrine therapy of hormone receptor positive (HR+) breast cancers, a significant number of patients with primary breast cancer continue to relapse, and those with stage IV disease face a median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc1b838548ad2c5bf8a0724d8d0845f9
https://doi.org/10.1158/1538-7445.sabcs15-p3-03-02
https://doi.org/10.1158/1538-7445.sabcs15-p3-03-02